The Liver Meeting 2023-Hepatitis B SIG - Optimizing Diagnosis & Mgt to Achieve Elimination

Hepatitis B SIG - Optimizing Diagnosis & Mgt to Achieve Elimination - 3120

Video Transcription

Video Summary

The video discusses the significance of novel biomarkers in understanding the Hepatitis B virus life cycle and improving monitoring and treatment decisions. Key biomarkers like quantitative surface antigen and core antigen provide insights into viral replication and protein expression, aiding in the management of the disease. These biomarkers also assist in identifying patients for antiviral therapy, monitoring treatment response, and predicting treatment outcomes. The use of these biomarkers simplifies treatment approaches and enhances treatment accuracy. The video also addresses the importance of patient perspectives in hepatitis B management, calling for patient-centered approaches, simplified guidelines, expanded treatment access, and the consideration of long-term patient experiences in guideline development. Discussions on reducing stigma, different treatment strategies like antiviral and immune modulation therapies, and the potential of gene editing for achieving a cure are highlighted. Overall, there is a push for personalized and effective treatment strategies in hepatitis B care based on a more inclusive and patient-centered approach.

Keywords

biomarkers

Hepatitis B virus

viral replication

protein expression

antiviral therapy

treatment response

treatment outcomes

patient perspectives

patient-centered approach

stigma reduction

immune modulation therapies

gene editing

personalized treatment strategies